Lanean...
Novel Immunotherapeutic Approaches in Head and Neck Cancer
Unresectable recurrent or metastatic head and neck cancer is an incurable disease with survival of approximately 12 months. Head and neck tumors exhibit numerous derangements in the tumor microenvironment that aid in immune evasion and may serve as targets for future therapies. Pembrolizumab is now...
Gorde:
| Argitaratua izan da: | J Cancer Metastasis Treat |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357897/ https://ncbi.nlm.nih.gov/pubmed/32661502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-4722.2019.32 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|